JP2015521848A5 - - Google Patents

Download PDF

Info

Publication number
JP2015521848A5
JP2015521848A5 JP2015520569A JP2015520569A JP2015521848A5 JP 2015521848 A5 JP2015521848 A5 JP 2015521848A5 JP 2015520569 A JP2015520569 A JP 2015520569A JP 2015520569 A JP2015520569 A JP 2015520569A JP 2015521848 A5 JP2015521848 A5 JP 2015521848A5
Authority
JP
Japan
Prior art keywords
cell
protein
seq
nucleic acid
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015521848A (ja
JP6067849B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/048571 external-priority patent/WO2014005019A2/en
Publication of JP2015521848A publication Critical patent/JP2015521848A/ja
Publication of JP2015521848A5 publication Critical patent/JP2015521848A5/ja
Application granted granted Critical
Publication of JP6067849B2 publication Critical patent/JP6067849B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520569A 2012-06-29 2013-06-28 組換えイズロン酸２スルファターゼを製造するための細胞 Active JP6067849B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261666719P 2012-06-29 2012-06-29
US61/666,719 2012-06-29
PCT/US2013/048571 WO2014005019A2 (en) 2012-06-29 2013-06-28 Cells for producing recombinant iduronate-2-sulfatase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016052380A Division JP6302499B2 (ja) 2012-06-29 2016-03-16 組換えイズロン酸２スルファターゼを製造するための細胞

Publications (3)

Publication Number Publication Date
JP2015521848A JP2015521848A (ja) 2015-08-03
JP2015521848A5 true JP2015521848A5 (https=) 2016-01-07
JP6067849B2 JP6067849B2 (ja) 2017-01-25

Family

ID=49778522

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015520569A Active JP6067849B2 (ja) 2012-06-29 2013-06-28 組換えイズロン酸２スルファターゼを製造するための細胞
JP2016052380A Active JP6302499B2 (ja) 2012-06-29 2016-03-16 組換えイズロン酸２スルファターゼを製造するための細胞
JP2018037376A Active JP6755272B2 (ja) 2012-06-29 2018-03-02 組換えイズロン酸２スルファターゼを製造するための細胞

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016052380A Active JP6302499B2 (ja) 2012-06-29 2016-03-16 組換えイズロン酸２スルファターゼを製造するための細胞
JP2018037376A Active JP6755272B2 (ja) 2012-06-29 2018-03-02 組換えイズロン酸２スルファターゼを製造するための細胞

Country Status (27)

Country Link
US (3) US9150841B2 (https=)
EP (1) EP2874649B1 (https=)
JP (3) JP6067849B2 (https=)
KR (1) KR101710487B1 (https=)
CN (2) CN107267460A (https=)
AU (3) AU2013282400B2 (https=)
BR (1) BR112014032560B1 (https=)
CA (1) CA2877521C (https=)
CL (1) CL2014003568A1 (https=)
CO (1) CO7240394A2 (https=)
CR (1) CR20140586A (https=)
DO (1) DOP2014000298A (https=)
EA (2) EA202090805A1 (https=)
ES (1) ES2718346T3 (https=)
GT (1) GT201400302A (https=)
HK (1) HK1209331A1 (https=)
IL (3) IL236343A (https=)
MX (2) MX336716B (https=)
MY (2) MY189314A (https=)
NZ (2) NZ734670A (https=)
PE (1) PE20150957A1 (https=)
PH (2) PH12016500011B1 (https=)
SG (2) SG11201408702VA (https=)
TR (1) TR201904435T4 (https=)
UA (1) UA118955C2 (https=)
WO (1) WO2014005019A2 (https=)
ZA (1) ZA201409396B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP2625189B1 (en) 2010-10-01 2018-06-27 ModernaTX, Inc. Engineered nucleic acids and methods of use thereof
AU2012236099A1 (en) 2011-03-31 2013-10-03 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US20160145589A1 (en) 2011-06-24 2016-05-26 Green Cross Corporation Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
CA3018046A1 (en) 2011-12-16 2013-06-20 Moderna Therapeutics, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
WO2013151665A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
JP6473079B2 (ja) * 2012-05-02 2019-02-20 ライフ テクノロジーズ コーポレーション 高密度増殖およびトランスフェクション培地並びに発現増強物質の固有の組み合わせを用いる、哺乳類細胞における高収率一過性発現
US20140004097A1 (en) * 2012-06-29 2014-01-02 Shire Human Genetic Therapies, Inc. Method of producing recombinant iduronate-2-sulfatase
KR101380740B1 (ko) 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
US9150841B2 (en) * 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase
WO2014028429A2 (en) 2012-08-14 2014-02-20 Moderna Therapeutics, Inc. Enzymes and polymerases for the synthesis of rna
PL2922554T3 (pl) 2012-11-26 2022-06-20 Modernatx, Inc. Na zmodyfikowany na końcach
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
WO2014152211A1 (en) 2013-03-14 2014-09-25 Moderna Therapeutics, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
US9550972B2 (en) 2014-09-29 2017-01-24 General Electric Company Devices, systems and methods for automated cell culturing
EP3101125A1 (en) * 2015-06-05 2016-12-07 Laboratorios Del Dr. Esteve, S.A. Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
EP3359670B2 (en) 2015-10-05 2024-02-14 ModernaTX, Inc. Methods for therapeutic administration of messenger ribonucleic acid drugs
CR20200129A (es) 2017-10-02 2020-08-22 Denali Therapeutics Inc Proteínas de fusión que comprenden enzimas de terapia de reemplazo de enzimas
JP7060235B2 (ja) * 2018-05-18 2022-04-26 国立大学法人広島大学 変異型イズロン酸－２－スルファターゼの機能回復薬剤のスクリーニング方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK6488D0 (da) 1988-01-07 1988-01-07 Novo Industri As Enzymer
US5310646A (en) 1988-05-13 1994-05-10 Regents Of The University Of Minnesota Method for the detection of mucopolysaccharide storage diseases
US5932211A (en) 1991-11-12 1999-08-03 Women's And Children's Hospital Glycosylation variants of iduronate 2-sulfatase
WO1995024920A1 (en) 1994-03-16 1995-09-21 The Regents Of The University Of California Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
US5863782A (en) 1995-04-19 1999-01-26 Women's And Children's Hospital Synthetic mammalian sulphamidase and genetic sequences encoding same
DE19527054A1 (de) 1995-07-26 1997-01-30 Behringwerke Ag Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen
AU4330597A (en) 1996-08-30 1998-03-19 Life Technologies, Inc. Serum-free mammalian cell culture medium, and uses thereof
WO2001018022A1 (en) 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 human secreted proteins
US7368531B2 (en) 1997-03-07 2008-05-06 Human Genome Sciences, Inc. Human secreted proteins
US7083793B2 (en) 1999-02-26 2006-08-01 Millennium Pharmaceuticals, Inc. Tango 243 polypeptides and uses thereof
EP2301947A3 (en) 1999-02-26 2011-11-23 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
US6506598B1 (en) 1999-04-26 2003-01-14 Genentech, Inc. Cell culture process
JP2002017376A (ja) 1999-07-08 2002-01-22 Herikkusu Kenkyusho:Kk 分泌蛋白質、または膜蛋白質
US6780627B1 (en) 2000-01-31 2004-08-24 Millennium Pharmaceuticals, Inc. 22438, 23553, 25278, and 26212 novel human sulfatases
AU2001238488A1 (en) 2000-02-17 2001-08-27 Incyte Genomics, Inc. Human kinases
EP1268541A1 (en) 2000-03-17 2003-01-02 Human Genome Sciences, Inc. 7 human ovarian and ovarian cancer associated proteins
EP2213743A1 (en) 2000-04-12 2010-08-04 Human Genome Sciences, Inc. Albumin fusion proteins
US20030148920A1 (en) 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
AU2002317700A1 (en) 2001-06-07 2002-12-16 Hemebiotech A/S Production of recombinant human arylsulfatase a
WO2003102132A2 (en) 2002-04-26 2003-12-11 Genetech, Inc. Non-affinity purification of proteins
US6890736B1 (en) 2002-09-20 2005-05-10 Immunex Corporation Methods for producing proteins in cultured cells
MXPA05006523A (es) 2002-12-23 2005-08-26 Squibb Bristol Myers Co Procesos de cultivo de celulas de mamiferos para la produccion de proteinas.
CA2515708A1 (en) 2003-02-11 2004-08-26 Transkaryotic Therapies, Inc. Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies
US20050019914A1 (en) 2003-07-24 2005-01-27 Aventis Pharma Deutschland Gmbh Perfusion process for producing erythropoietin
WO2005113765A2 (en) 2004-05-06 2005-12-01 Biomarin Pharmaceutical Inc. Methods of activation of sulfatases and methods and compositions of using the same
AU2006254103B2 (en) 2005-06-03 2012-09-06 Ares Trading S.A. Production of recombinant IL-18 binding protein
CA2645739A1 (en) 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
CA2711590C (en) 2008-01-18 2021-03-23 Biomarin Pharmaceutical Inc. Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
CN102665890B (zh) * 2009-10-09 2016-02-24 蓝立方知识产权公司 生产氯化和/或氟化丙烯和高级烯烃的绝热活塞流反应器及方法
EP2485761B1 (en) 2009-10-09 2019-02-27 Armagen, Inc. Methods and compositions for increasing iduronate 2-sulfatase activity in the cns
WO2011108451A1 (ja) 2010-03-01 2011-09-09 日本ケミカルリサーチ株式会社 遺伝子ノックアウト細胞を用いた組換え体リソソーム酵素の製造方法
KR20230159646A (ko) 2010-06-25 2023-11-21 샤이어 휴먼 지네틱 테라피즈 인크. 이듀로네이트-2-설파타제의 cns 전달을 위한 방법들 및 조성물들
WO2012101671A1 (en) 2011-01-25 2012-08-02 Jcr Pharmaceuticals Co., Ltd. Method for production of human recombinant iduronate 2-sulfatase
KR101158673B1 (ko) 2011-06-24 2012-07-03 주식회사 지씨바이오 재조합 인간 이듀로네이트-2-설파타아제를 포함하는 조성물, 제제 및 이의 제조방법
US20140004097A1 (en) 2012-06-29 2014-01-02 Shire Human Genetic Therapies, Inc. Method of producing recombinant iduronate-2-sulfatase
KR101380740B1 (ko) 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
US9150841B2 (en) 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase

Similar Documents

Publication Publication Date Title
JP2015521848A5 (https=)
JP2016105737A5 (https=)
MX353610B (es) Método para producir un polipéptido o virus de interés en un cultivo de células continuo.
IN2014DN03419A (https=)
MX2012003654A (es) Metodos de produccion de glucoproteinas en cultivos de celulas de mamiferos usando glucocorticoides.
JP2014524241A5 (https=)
NZ605403A (en) Method of producing recombinant adamts13 in cell culture
PH12015501837B1 (en) Manufacturing methods to control c-terminal lysine, galactose and sialic acid content in recombinant proteins
WO2011091350A3 (en) Methods & compositions for improving protein production
JP2013545491A5 (https=)
WO2008126784A1 (ja) グルタチオンおよびγ-グルタミルシステインの製造法
MY166220A (en) Rabies virus like particle production in plants
JP2015523074A5 (https=)
JP2014076042A5 (https=)
CN106754447B (zh) 重组酿酒酵母及其在合成丙谷二肽中的应用
JP2016513457A5 (https=)
MY184072A (en) Increasing virus like particle yield in plants
JP2020506722A5 (https=)
MX2019000075A (es) Metodo para la produccion fermentativa de moleculas de interes por microorganismos que comprenden genes que codifican el sistema de fosfotransferasa de azucar (pts).
IN2014DN00094A (https=)
CN104561076B (zh) 一种高产l‑丝氨酸重组谷氨酸棒杆菌的构建及其发酵方法
JP2021529527A5 (https=)
CN107287144A (zh) 一种代谢改造的枯草芽孢杆菌生物转化细胞及其制备方法与应用
CN105368808A (zh) 一种IdeS蛋白酶、其制备方法及应用
CN102911960B (zh) 一种减弱反馈抑制菌株生产谷胱甘肽的方法